Health authorities have intensified the rollout of the Human papillomavirus (HPV) vaccination campaign, aiming to significantly expand protection against cervical cancer among adolescents. The renewed push focuses on increasing immunisation coverage in schools, community health centres, and rural outreach camps to ensure wider access to the life-saving vaccine.
HPV is a common viral infection transmitted through skin-to-skin contact, and certain high-risk strains are known to cause cervical cancer. According to the World Health Organization, widespread vaccination of adolescent girls—ideally before exposure to the virus—can dramatically reduce the incidence of cervical cancer and related diseases.
Under the expanded drive, trained health teams are conducting awareness sessions for parents, teachers, and students to address concerns and dispel myths about vaccine safety. Officials have emphasized that the HPV vaccine is safe, effective, and approved by global and national regulatory bodies. In addition to school-based programmes, special vaccination days are being organised in underserved areas to ensure no eligible beneficiary is left out.
The campaign also aligns with broader public health goals to eliminate cervical cancer as a public health problem in the coming decades. By improving immunisation rates and promoting early prevention, authorities aim to reduce the long-term burden of cancer treatment and improve women’s health outcomes nationwide.
Further expansion phases are expected in the coming months as part of sustained preventive healthcare initiatives news as reported.
